Paperpal Prime Logo

Therapeutic Innovation and Regulatory Science : Impact Factor & More

eISSN: 2168-4804pISSN: 2168-4790

Aims and Scope of Therapeutic Innovation and Regulatory Science

Therapeutic Innovation & Regulatory Science is a bimonthly peer-reviewed medical journal that covers research and developments concerning pharmaceuticals and the development and use of medical products. It is published by Sage Publications on behalf of the Drug Information Association. The journal was established in 1967 as the Drug Information Bulletin and renamed to Drug Information Journal in 1971, before obtaining its current title in 2013. The editor-in-chief is Stephen P. Spielberg. Less

Key Metrics

CiteScore
2.2
H-Index
48
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
0.6
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Therapeutic Innovation and Regulatory Science

Therapeutic Innovation and Regulatory Science Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGER HEIDELBERG
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1966
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Therapeutic Innovation and Regulatory Science ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Therapeutic Innovation and Regulatory Science

Psychotropic Drug Scheduling and Benzodiazepine Receptor Agonist Prescribing in Japan: An Interrupted Time Series Analysis.
  • 8 Aug 2026
  • Therapeutic innovation & regulatory science
Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.
  • 8 Aug 2026
  • Therapeutic innovation & regulatory science
The Changing Landscape of Global Biopharmaceutical Leadership, 2004-2024.
  • 7 Aug 2026
  • Therapeutic innovation & regulatory science
Correction to: BOP2-Comb: Bayesian Optimal Phase II Design for Optimizing Doses and Assessing Contribution of Components in Drug Combinations.
  • 1 Aug 2026
  • Therapeutic innovation & regulatory science
Integral Drug-Device Combinations and Medical Device Regulation Article 117: The European Medicines Agency Perspective.
  • 1 Aug 2026
  • Therapeutic innovation & regulatory science
Key Real-World Data Management Practices for Registry Evaluation and Quality Assurance.
  • 1 Aug 2026
  • Therapeutic innovation & regulatory science
Psychotropic Drug Scheduling and Benzodiazepine Receptor Agonist Prescribing in Japan: An Interrupted Time Series Analysis.
  • 8 Aug 2026
  • Therapeutic innovation & regulatory science
Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.
  • 8 Aug 2026
  • Therapeutic innovation & regulatory science
The Changing Landscape of Global Biopharmaceutical Leadership, 2004-2024.
  • 7 Aug 2026
  • Therapeutic innovation & regulatory science
Correction to: BOP2-Comb: Bayesian Optimal Phase II Design for Optimizing Doses and Assessing Contribution of Components in Drug Combinations.
  • 1 Aug 2026
  • Therapeutic innovation & regulatory science
Integral Drug-Device Combinations and Medical Device Regulation Article 117: The European Medicines Agency Perspective.
  • 1 Aug 2026
  • Therapeutic innovation & regulatory science
Key Real-World Data Management Practices for Registry Evaluation and Quality Assurance.
  • 1 Aug 2026
  • Therapeutic innovation & regulatory science

FAQs on Therapeutic Innovation and Regulatory Science